Question: why did bms acquire celgene?
Answer: Bristol-Myers Squibb to Acquire Celgene to Expand its Cancer Portfolio. ... In their press release, BMS said that the Celgene acquisition was in line with their vision of creating a “premier innovative biopharma company.”